Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadir Kadri

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Expert Review of Clinical Immunology|May 19, 2010
Type II natural killer T cells: a new target for immunomodulation?Nadir Kadri, Maria Blomqvist, Susanna L Cardell
Revue De L'Infirmiere|November 13, 2018
[The use and consequences of physical restraint in geriatric care]Abrar-Ahmad Zulfiqar, Jean Doucet, Nadir Kadri
Immunological Reviews|August 19, 2015
Selection, tuning, and adaptation in mouse NK cell educationNadir Kadri, Thuy Luu Thanh, Petter Höglund
Presse Medicale (Paris, France : 1983)|August 16, 2005
[Mental confusion in the elderly]Philippe Chassagne, Laurent Druesne, Caroline Bentot, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|June 8, 2018
Pharmacoclinical audit on the use of digitalis in patients aged over 75 years hospitalized in an acute geriatric unitAbrar-Ahmad Zulfiqar, Paul Blazejczyk, Nadir Kadri, et al.
Soins. Gerontologie|July 9, 2017
Maxime Majot, Nadir Kadri, Jean Doucet, et al.
Chemotherapy|March 16, 2007
Pharmacokinetics of imipenem in sheep with special reference to its hepato-renal effectsK Abo EL-Sooud, W Khammas, M Nadir Kadri
Stem Cells (Dayton, Ohio)|September 28, 2016
Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated ImmunosuppressionLindsay C Davies, Nina Heldring, Nadir Kadri, et al.
Soins. Gerontologie|May 16, 2019
[Geriatrics and e-technology in an institution]Abrar-Ahmad Zulfiqar, Nadir Kadri, Jean Doucet, et al.
Cellular & Molecular Immunology|May 10, 2023
Current perspectives on mesenchymal stromal cell therapy for graft versus host diseaseNadir Kadri, Sylvie Amu, Ellen Iacobaeus, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Expert Review of Clinical Immunology|May 19, 2010
Type II natural killer T cells: a new target for immunomodulation?Nadir Kadri, Maria Blomqvist, Susanna L Cardell
Revue De L'Infirmiere|November 13, 2018
[The use and consequences of physical restraint in geriatric care]Abrar-Ahmad Zulfiqar, Jean Doucet, Nadir Kadri
Immunological Reviews|August 19, 2015
Selection, tuning, and adaptation in mouse NK cell educationNadir Kadri, Thuy Luu Thanh, Petter Höglund
Presse Medicale (Paris, France : 1983)|August 16, 2005
[Mental confusion in the elderly]Philippe Chassagne, Laurent Druesne, Caroline Bentot, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|June 8, 2018
Pharmacoclinical audit on the use of digitalis in patients aged over 75 years hospitalized in an acute geriatric unitAbrar-Ahmad Zulfiqar, Paul Blazejczyk, Nadir Kadri, et al.
Soins. Gerontologie|July 9, 2017
Maxime Majot, Nadir Kadri, Jean Doucet, et al.
Chemotherapy|March 16, 2007
Pharmacokinetics of imipenem in sheep with special reference to its hepato-renal effectsK Abo EL-Sooud, W Khammas, M Nadir Kadri
Stem Cells (Dayton, Ohio)|September 28, 2016
Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated ImmunosuppressionLindsay C Davies, Nina Heldring, Nadir Kadri, et al.
Soins. Gerontologie|May 16, 2019
[Geriatrics and e-technology in an institution]Abrar-Ahmad Zulfiqar, Nadir Kadri, Jean Doucet, et al.
Cellular & Molecular Immunology|May 10, 2023
Current perspectives on mesenchymal stromal cell therapy for graft versus host diseaseNadir Kadri, Sylvie Amu, Ellen Iacobaeus, et al.
Pageof 6